Submission of a New Drug Application for Pancreatic Enzyme Replacement Therapy Agent SA-001 in Japan

  Tokyo, Dec 24, 2009 - (JCN Newswire) - A New Drug Application for the pancreatic enzyme replacement therapy agent for pancreatic exocrine insufficiency, SA-001 (API name: Pancrelipase) that Solvay Seiyaku K. K. co-developed with Eisai Co., Ltd. was submitted by Solvay Seiyaku on December 22, 2009 in Japan.  

Sydney

  [ Change ]
 
Today

Rain.
Tomorrow

Min: 15°
Max: 15°
Rain easing.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online